Evidence map›Paper›PMID 42535614›Full record

ArticleFEBS open bio2026

Avidin is evolutionarily conserved in fish but dispensable for development and resistance against Streptococcus agalactiae in zebrafish.

Anni K Saralahti, Markus J T Ojanen, Mataleena Parikka, Otto Kauko, Mika Rämet, Vesa P Hytönen

Abstract read
In one paragraph

Article in FEBS open bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anni K SaralahtiFaculty of Medicine and Health Technology, Tampere University, Finland.
Markus J T OjanenFaculty of Medicine and Health Technology, Tampere University, Finland.ORCID https://orcid.org/0000-0001-6623-844X
Mataleena ParikkaFaculty of Medicine and Health Technology, Tampere University, Finland.
Otto KaukoTurku Bioscience Centre, University of Turku and Åbo Akademi University, Finland.
Mika RämetFaculty of Medicine and Health Technology, Tampere University, Finland.
Vesa P HytönenFaculty of Medicine and Health Technology, Tampere University, Finland.

Funding

Research Council of FinlandSigrid Juséliuksen SäätiöSyöpäsäätiöTampereen Tuberkuloosisäätiö
6 · The paper itself

Abstract

Biotin is a vital cofactor in cellular carboxylation reactions and avidins are biotin-binding proteins that are produced by bacteria and fungi but also by egg-laying vertebrates, including avian species and zebrafish (Danio rerio). Although avidins have proposed roles in embryonic development and immunity, their biological significance is poorly characterized. Moreover, besides zebrafish, the presence of avidins in other fish species has not been explored. Here, we cataloged avidins in fish species and demonstrate that avidins exist in lobe-finned fish (Sarcopterygii), cartilaginous fish (Chondrichthyes) and ray-finned fish (Actinopterygii), and that the biotin-binding amino acids in fish avidins are evolutionarily conserved. To evaluate the significance of avidin in embryonic development, we created avd knockout (KO) zebrafish and show that zebavidin (zebrafish avidin) is dispensable for fish development. We also assessed the survival of the avd KO embryos from Streptococcus agalactiae infection and demonstrate that the resistance of the embryos is not altered in the absence of zebavidin. Collectively, we show that avidins exist widely in fish species and provide new insights into avidin biology by demonstrating that zebavidin is not essential for zebrafish development or response to S. agalactiae.

Indexed as

avidinbacterial infectionCRISPR/Cas9developmentphylogenyzebrafish

Identifiers

PMID42535614
PMCPMC13425791

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.